Hassan, T A, Hollander, S, van Lent, L, Schwedeler, M and Tahoun, A
(2023)
Firm-Level Exposure to Epidemic Diseases: COVID-19, SARS, and H1N1.
Review of Financial Studies, 36 (12).
pp. 4919-4964.
ISSN 0893-9454
Abstract
We construct text-based measures of the primary concerns listed firms associated with the spread of COVID-19 and other epidemic diseases. We identify which firms perceive to lose or gain from a given epidemic and textually decompose the epidemic's effect on the firm's demand and supply. We find that the effects of COVID-19 manifest as a simultaneous shock to demand and supply, with both shocks affecting firms’ market valuations in equal measure on average. By contrast, demand-related impacts appear more important in accounting for the observed collapse in firm-level investment during the COVID-19 crisis.
More Details
Item Type: | Article |
---|---|
Subject Areas: | Accounting |
Additional Information: |
This is a pre-copyedited, author-produced version of an article accepted for publication in The Review of Financial Studies following peer review. The version of record Tarek A Hassan, Stephan Hollander, Laurence van Lent, Markus Schwedeler, Ahmed Tahoun, Firm-Level Exposure to Epidemic Diseases: COVID-19, SARS, and H1N1, The Review of Financial Studies, Volume 36, Issue 12, December 2023, Pages 4919–4964, is available online at: https://academic.oup.com/rfs/article-abstract/36/12/4919/7169147 https://doi.org/10.1093/rfs/hhad044 |
Date Deposited: | 21 Jun 2023 11:42 |
Date of first compliant deposit: | 04 Dec 2023 |
Subjects: |
Professional firms Macroeconomics |
Last Modified: | 10 Jun 2025 01:28 |
URI: | https://lbsresearch.london.edu/id/eprint/2919 |